Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases

Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases

Abstract Background The indications for fertility preservation (FP) have expanded. A few patients who underwent gonadotoxic treatment did not have the opportunity to receive FP, leading to concerns that these patients may develop premature ovarian insufficiency. However, the usefulness of FP in wome...

Full description

Bibliographic Details
Main Authors: Saki Saito, Mitsutoshi Yamada, Rika Yano, Kazuko Takahashi, Akiko Ebara, Hiroe Sakanaka, Miho Matsumoto, Tomoko Ishimaru, Hiroki Utsuno, Yuichi Matsuzawa, Reina Ooka, Mio Fukuoka, Kazuhiro Akashi, Shintaro Kamijo, Toshio Hamatani, Mamoru Tanaka
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Ovarian Research
Subjects:
Cancer
Autoimmune disease
Fertility preservation
Gonadotropin-releasing hormone analogue
Progestin-primed ovarian stimulation
Female infertility
Online Access:https://doi.org/10.1186/s13048-023-01250-x

Internet

https://doi.org/10.1186/s13048-023-01250-x

Similar Items